Olatec is a privately held biopharmaceutical company developing a platform of safe, oral NLRP3 antagonist therapeutics, to treat and prevent a broad spectrum of acute and chronic inflammatory diseases that are known to be mediated by Interleukin-1 (IL-1), including: arthritis, heart failure, asthma, Alzheimer’s disease, multiple sclerosis, type-2 diabetes, melanoma and breast cancers, among others.

Pharmaceutical

Olatec Therapeutics

Damaris B. Skouras

Piscitelli Philip

Jeanette Rooney, CPA, CGMA

Cynthia (Dana) Barrow

Mustafa Noor

Joseph St. Laurent

Charles A. Dinarello

The leadership team at Olatec Therapeutics has a lot of experience in the industry. They have worked with big names like Morgan Stanley and Allen & Company. They also have a lot of education between them. The team is very qualified to lead the company.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Olatec Therapeutics

Board of Directors

CEO and Executive Team